The surface marker CD103 is considered crucial for identifying tumor-infiltrating CD8+ T lymphocytes, and HCC patients with elevated levels of CD103-expressing CD8+ T cells exhibit improved survival rates compared to those with lower expression of this infiltrating cell population (26). This evidence concerns the gene ITGAE and neoplasm.